Genetic predisposition study of heart failure and its association with cardiomyopathy

Vaishak Kaviarasan1, Vajagathali Mohammed1, Ramakrishnan Veerabathiran2

  • 1Human Cytogenetics and Genomics Laboratory, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamilnadu, 603103, India.

Insights

Genetic factors significantly contribute to heart failure (HF), particularly through cardiomyopathy. Understanding these genetic variants is crucial for developing personalized HF treatments.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Heart failure (HF) is a complex clinical condition involving myocardial structural and functional defects, influenced by genetic and environmental factors.
  • The incidence of HF is estimated between 1-2% in developed countries, with genetic factors, especially cardiomyopathy, being a common cause.
  • Existing research highlights the heterogeneity and complexity of genetic factors contributing to HF progression.

Purpose of the Study:

  • To investigate the association between heart failure (HF) and cardiomyopathy, focusing on their underlying genetic variants.
  • To identify novel genes implicated in the pathogenesis and progression of inherited human cardiomyopathy and HF.
  • To enhance the understanding of the genetic basis of HF for improved diagnostic accuracy and therapeutic strategies.

Main Methods:

  • Literature review and data collection from human gene mutation databases and other relevant research sources.
  • Analysis of genetic variants linked to inherited cardiomyopathy.
  • Examination of the role of identified genes in the molecular pathophysiology of HF.

Main Results:

  • Numerous genes have been identified and linked to cardiomyopathy, confirming a significant hereditary influence on the condition.
  • Selected novel genes demonstrate a critical role in the pathogenesis and progression of HF.
  • Findings provide robust evidence supporting the genetic underpinnings of HF.

Conclusions:

  • Understanding the genetic architecture of HF, particularly its link to cardiomyopathy, is essential.
  • The identified genetic variants offer insights into HF etiology and progression.
  • Enhanced knowledge of genetically driven HF pathophysiology may pave the way for personalized therapeutic interventions.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
109
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
103
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
92
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
52